Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the <scp>FAERS</scp> Database
This study provides real-world evidence for the safety evaluation of upadacitinib and underscores the need to monitor sex-specific adverse events. Future prospective studies are necessary to confirm these pharmacovigilance findings.
Authors
- Yuepu Pu (ORCID: https://orcid.org/0000-0003-4710-3018)
- Xulei Zuo (ORCID: https://orcid.org/0000-0003-2235-681X)
- Hongxia Lu (ORCID: https://orcid.org/0000-0002-0181-3113)
- Jiayu Yuan (ORCID: https://orcid.org/0000-0002-6576-8630)
- Juan Zhang (ORCID: https://orcid.org/0000-0002-4974-4540)
- Lihong Yin
Institutions
- Nanjing Sport Institute (CN)
- Southeast University (CN)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1002/pds.70030
- Citations
- 7
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.45